Patients and Medical
Patient engagement: Breaking through in digital
The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential
More Patients and Medical Articles
Patients and Medical
Amplifying the patient voice in rare disease access
Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom
Patients and Medical
From complexity to clarity in cell and gene therapy
Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
Patients and Medical
The future of Medical Affairs: A virtual Q&A with Charlotte Kremer
The Astellas head of medical affairs follows up with answers to questions during her virtual keynote earlier this year
Access and Evidence
Survey results: Accelerating digital transformation during COVID-19
View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Patients and Medical
The future of medical congresses
The mega congresses of the past look likely to make way for more virtual, focused and, probably, hybrid physical/digital events
Patients and Medical
Patient centricity: Mind the capacity gap
If pharma wants patients and patient groups capable of working with it at every stage of the drug development process it must listen to, and contribute to training and funding them
Patients and Medical
What patients need right now
In the face of massive patient need, there’s plenty pharma can do to help. The crisis is also an opportunity for it to transform the way it works with patients.
Patients and Medical
The emerging patient-centricity landscape in Japan
Change is happening in patient engagement as Japan's pharma pioneers begin to lay strong foundations for a richer future
Patients and Medical
Building a bridge to a COVID-19 vaccine
Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual